Navigation Links
AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System)
Date:1/28/2009

ion to our EDC and possibly our financial system, as well as other innovative functional changes to the system that will give us clear advantages in the service we can provide to our clients," said Anne Wiles, Senior Vice President, Data Systems and Process, AAIPharma.

"We are excited to be working with AAIPharma who was successful for a number of years with their Lotus notes CTMS system. The deployment of Clinical Force will build on the work they had previously done delivering even greater efficiencies, visibility and support to AAIPharma's exciting global growth. We believe we have more CRO customers than any other CTMS vendor. Knowing that most other legacy CTMS solutions were not affordable by small to mid size companies, we developed our system to meet an underserved market, said Marcus Thornton, CEO and President, Clinical Force. Our strong functionality and SaaS deployment model are a perfect combination for CROs conducting global trials."

About Clinical Force
Clinical Force delivers a fully functional Clinical Trials Management System (CTMS) to Clinical Research Organizations and Sponsors. Clinical Force is the first company to deliver the CTMS in the Software as a Service (SaaS) model enabling quick installation and a cost effective solution. Organizations in North America, South America, Africa and Europe are successfully using the CTMS to improve internal efficiencies and real time visibility of all studies from an easy to use web based solution. Clinical Force is a privately held company with strong life science pedigree, the company has offices in the US and Europe. www.clinicalforce.com

About AAIPharma
AAIPharma Inc. is a global provider of product development and support services to the pharmaceutical, biotechnology and medical device industries. From a single test through a range of integrated services
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange
2. GHI Medical Deploys New Test to Help Determine Hair Loss
3. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
4. Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
5. Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert
6. IntraLinks Poll: Half of Clinical Trial Management Professionals Share Critical Information Via E-Mail
7. Intelligroup Secures Multi-Million Dollar COSMOS Implementation with Almac Clinical Services
8. MAP Pharmaceuticals Announces Completion of Enrollment in Phase 3 Clinical Trial of MAP0004 in Patients with Migraine
9. ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication
10. Christopher and Dana Reeve Foundation Response to FDA Clearance of Gerons Clinical Trial
11. MultiVu Video Feed: Geron Receives FDA Clearance to Begin Worlds First Human Clinical Trial of Embryonic Stem Cell-Based Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...e able to charge their cell phones and other perso...t discovery made by UC San Diego engineers could l...could do just this. , In recent research, publi...ru, a professor in the UCSD Department of Mechanic...student Mark Hoefer, have found that artificially ...
(Date:11/19/2009)..., Md., Nov. 19 Spherix I...echnology for diabetes therapy, and a provider of ...od, supplement, biotechnology and pharmaceutical c... reported $6.3 million registered direct placement... its common stock and warrants to purchase up to 1...
(Date:11/19/2009)...any, November 19 MONITORING FORCE ...th, 2009 Flibanserin in the,indication treatment-r...,disease for orphan drug status designation with t...ced dyskinesia is a complication of the mainstay,t...den to some of those,affected, since it may be dis...
(Date:11/19/2009)...nd is honored by latest award for revolutionary he...PRWEB) November 16, 2009 -- Popular Science Magazi...ring aid from InSound Medical a winner of its cove...ategory.    Chosen from thousa...in the hearing canal for up to four months while p...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
... - Bruker AXS , a supplier of X-ray solutions for...BioSciences , announced on Tuesday the introductio...roduct lines. , ,The new systems were unveiled at...eeting in Florence, Italy. , ,Axiom 200, a new dig...stallography, was designed with zero detector nois...
...ness investors and government representatives have...5 that was enacted to stimulate investments in hig...e to a state Senate committee on Wednesday. For mo...mie business investment in high-growth companies ...dations: , , Increasing from $30 million to $60 mi...
.... -- The Medical College of Wisconsin has receive...nisms by which inhaled anesthetics protect the hum...d flow like those occurring during heart surgery. ...y of xenon and heart injuries. , ,Zeljko Bosnjak, ...gy and professor of physiology, is the principal i...
Other Biology Technology:Suggestions offered to foster high-growth business investment 2
(Date:11/20/2009)...T researchers are at work on many scientific and t...ation has recently provided support that totals ne...ollowing investigators under the American Recovery...ers have been awarded grants for investigation of ...ofessor of physics, will enhance the capabilities ...
(Date:11/20/2009)... highly precise measurements of plasma lipoprotein...onance spectroscopy (NMR), researchers led by Dani...vard Medical School in Boston, MA, the Framingham ...rtium in Stockholm, Sweden and Oxford, England per...le genome among 17,296 women of European ancestry ...
(Date:11/20/2009)...shington, DC Nov. 20, 2009) Scientists from the ...sections of the Naval Research Laboratory (NRL) or...t scientists on an Arctic expedition to initiate m... determine the spatial variation of sediment contr...e U.S. Coast Guard Cutter Polar Sea as a research ...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2International expedition investigates climate change, alternative fuels in Arctic 2Burger 3A Congress Must Act Now on Health Care 56696 1Fattah 3A Waiting Time is Over on Healthcare 56691 1In Letter to President TPC Highlights Foundation Grants in Health 56686 1In Letter to President TPC Highlights Foundation Grants in Health 56686 2In Letter to President TPC Highlights Foundation Grants in Health 56686 3
...tainly not free of risk. Since 2005, the poison em...nd Gttingen have registered a total of 17 patients...g capsules. The pharmacologist Dieter Mller and hi...ning in the current edition of Deutsches rzteblat... 218-22). , The authors report on a slimming pill...
...l house made of bamboo now stands in Changsha, Hun...professor at the USC Viterbi School of Engineering...Modern Bamboo, Timber and Composite Structures of ...ed the house, among the first of its kind in the w...y Xiao, a technology named by Popular Science ma...
... cancer has shown considerable promise in early cl... become resistant to current drugs. , Of 30 men w...ite phase I/II trial designed to evaluate safety, ...tate specific antigen (PSA) in their blood. Phase ...ug,s effect on survival in a large group of patien...
Other Biology News:A full-sized California-style home made of bamboo 2New medications show promise in treating drug-resistant prostate cancer 2New medications show promise in treating drug-resistant prostate cancer 3New medications show promise in treating drug-resistant prostate cancer 4
Anti-Monocarboxylate Transporter 2 (MCT2) Polyclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Human Kallikrein 2 Monoclonal Antibody, Unconjugated, Clone 6B7 from ImmuQuest Ltd.
Rabbit Anti-Asb-2 Polyclonal Antibody, Unconjugated from IMGENEX
Anti-TWIK-2 (Kcnk6, TOSS) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: